AI- and Model-Based Tools to Streamline Drug Development

AI- and Model-Based Tools to Streamline Drug Development

Brought to you by Lonza

Overview

Drug development is increasingly complex, with small-molecule APIs requiring more synthetic steps and presenting greater scale-up challenges. These factors, combined with high failure rates and long timelines, demand smarter strategies to reduce risk and accelerate progress. This e-book explores how AI-driven route scouting, high-throughput experimentation (HTE), and advanced modeling platforms can help chemists design robust, scalable processes earlier—minimizing delays and resource waste while improving confidence in candidate viability.

Key Objectives:

Explain how AI-enabled route scouting optimizes synthesis beyond theoretical efficiency.
Show how HTE accelerates process optimization through parallel experimentation.
Introduce Design2Optimize™ for predictive, model-based process development.
Highlight integrated CDMO partnerships that mitigate risk and streamline timelines.

Brought to you by:

Please complete the form to download the e-book.

Forwarded this link? Clear the form

Email Address*

Salutation*

First Name*

Last Name*

Company*

Job Title

Address 1*

City*

State*

Zip / Post Code*

Country/Territory/Area*

Business Phone*

Are you currently working on or planning to start an early-phase small-molecule project?*

Would you be interested in leveraging advanced tools such as high-throughput experimentation (HTE) or model-based optimization (Design2Optimize™) to accelerate your timelines?*

I would like to receive C&EN’s weekly newsletter with the latest in chemistry news

I would like to receive more information on products and services from the American Chemical Society

address2

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.